Table 2. Laboratory test results and treatment adherence.
| Variable | Baseline | Week 4 | Week 12 | End of treatment | 12 weeks after the end of treatment |
|---|---|---|---|---|---|
| Hemoglobin g/L (mean ± *SD) | 140.76 ± 19.79 | 128.61 ± 22.54 | 127.33 ±17.97 | 126.98 ± 21.58 | 141.23 ± 19.72 |
| Platelets ×10⁹/L (mean ± *SD) | 146.15 ± 69.59 | 163.47 ± 77.16 | 136.92 ± 71.82 | 162.95 ± 75.21 | 156.78 ± 70.27 |
| Viral load (RNA Log10 IU/ml) (mean ± *SD) | 6.05 ± 0.75 | 1.37 ± 0.29 | Undetectable | Undetectable | Undetectable |
| Albumin g/L (mean ± *SD) | 42.09 ± 5.41 | 42.21 ± 4.81 | 41.46 ± 4.94 | 41.91 ± 5.18 | 43.68 ± 4.09 |
| **INR (mean ± *SD) | 1.25 ± 0.42 | 1.23 ± 0.35 | 1.41 ± 0.54 | 1.29 ± 0.52 | 1.21 ± 0.28 |
| Bilirubin mg/dL (median****(IQR)) | 0.7 (0.7) | 0.9 (0.9) | 0.85 (1.05) | 0.7 (0.9) | 0.6 (0.45) |
| ***ALT U/L (median****(IQR)) | 61 (55) | 19 (10) | 18 (11) | 16 (9) | 17.5 (10) |
| Neutrophils ×10⁹/L (mean ± *SD) | 3.71(4.4) | 3.58 (1.6) | 3.36 (1.58) | 3.48(1.68) | 3.58(1.6) |
| Adherence | - | 100% | 100% | 100% | - |
*SD, Standard deviation
**INR, International Normalized Ratio
***ALT, Alanine aminotransferase
****IQR (interquartile range)